The TLR players | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

  •  Special $399 Lifetime Membership offer ends soon:
    For anyone who may have missed the memo posted last week, in August of 2018 we offered a limited number of 1-yr options to purchase Lifetime Premium Memberships. Fewer than 2 dozen remain unexercised. Rather than allow them to expire worthless, we are making them available to serious takers on an exclusive
    first come, first served basis. CLICK HERE to lock in a lifetime of benefits & savings!

  • Not sure what all the "Premium Service" fuss is all about? 

    Watch this 2 minute video to find out.

  • Only 11 
    Lifetime Premium Memberships left

IDRA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1478 of 1514  at  7/20/2019 7:37:23 PM  by


The following message was updated on 7/20/2019 7:40:20 PM.

 In response to msg 1477 by  raferjack
view thread

Re: The TLR players

In my opinion, Idera has the right combo with IPI. Of all of these combos, IPI enhances CD4 effector cells. This is the advantage...on paper. Results to be determined.

I highly suggest adding Opdivo to the combo. You must address PD-L1 with an anti-PD1 once the tumor goes hot. No getting around that.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 89
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
1479 Re: The TLR players vorlon1966 0 7/20/2019 7:41:52 PM
1480 Re: The TLR players vorlon1966 0 7/20/2019 7:47:32 PM
1483 Re: The TLR players raferjack 0 7/21/2019 1:39:09 PM

About Us  �  Contact Us  �  Follow Us on Twitter  �  Members Directory  �  Help Center  �  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
� 2003-2018 All rights reserved. User Agreement
Financial Market Data provided by